Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lot Consistency of Plant-Derived Quadrivalent VLP Influenza Vaccine in Adults
NCT03321968Phase 3Completed
- Sponsor
- Medicago Inc.
- Start
- Sep 2017
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in influenza (3 arms), sponsored by Medicago Inc. Primary endpoint: Geometric Mean Titers of Hemagglutination Inhibition Antibody Response at Day 21. Started Sep 2017; status: completed.
02
Conditions
influenza
Beyond the preview
Go deeper on NCT03321968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03321968.